Chennai, 4th October 2009 Vaso-Meditech Pvt Ltd, the exclusive distributor and clinical support provider for EECP and SphygmoCor devices in India, successfully organized its 2nd National Expert Committee Meeting on EECP Therapy on 3rd October 2009 at Hotel Clarks Inn, Pacific Mall, Ghaziabad. The event was attended by leading cardiologists, general physicians, EECP providers, and renowned heart specialists from across the country to discuss advancements in non-invasive cardiac care and the growing importance of EECP therapy for coronary artery disease. Special invited guests Dr. James Sharman from the University of Tasmania, Australia, and Mr. Mark Harding from AtCor Medical Pty Ltd, Australia, participated in the meeting and shared valuable insights on vascular health, cardiac diagnostics, and modern treatment technologies. The conference highlighted the clinical effectiveness of EECP therapy for coronary artery disease in improving blood circulation, reducing angina symptoms, enhancing cardiac performance, and supporting long-term heart health without surgery. Experts also emphasized the increasing adoption of EECP treatment by leading heart centers across India as a safe and effective alternative treatment for patients suffering from coronary artery disease and chronic heart conditions. Vaso-Meditech Pvt Ltd continues its commitment to promoting advanced non-invasive cardiac care solutions and supporting healthcare professionals with innovative technologies for better patient outcomes.
EECP THERAPY uses a proprietary technology to inflate and deflate a series of pneumatic cuffs enclosing the lower extremities of the patients. Treatment is administered on a padded table in which three sets of electronically controlled inflation and deflation valves are located.
